Prevalence and Genetic Alternation of Autoimmune Polyglandular Syndrome Type II in Taiwan

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

650 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-01-01

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Autoimmune polyendocrine syndrome (APS) is an autoimmune disease involving at least two endocrine organ. It is classified into type I and type II diseases. Among them, APS type II is more common. It is diagnosed when two of the three following diseases are diagnosed in the same patient, including type 1 diabetes mellitus, autoimmune thyroid disease, and primary adrenal insufficiency. In this study, we will observe the epidemiology, clinical characteristics, and genetic variants of APS II in Taiwan.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Retrospective Study for Multiple Endocrine Neoplasia

NCT05812573

Multiple Endocrine Neoplasia

UNKNOWN

The Association of Costimulatory Molecules and PPAR-polymorphisms With Autoimmune Thyroid Disease in Taiwan

NCT01260532

AITd Patients With Different Polymorphisms

UNKNOWN

Verification of the Epidemiology and Mortality of Rare Diseases in Taiwan With Real-world Evidence

NCT05367115

Rare Diseases Epidemiology Morbidity +3 more

COMPLETED

The Genetic Study of Primary Angle-Closure Glaucoma

NCT00155857

Glaucoma

UNKNOWN

Mitochondrial nt3243 A>G Mutation in Taiwan

NCT02114554

MELAS Syndrome Noninsulin-dependent Diabetes Mellitus With Deafness

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Autoimmune Polyendocrine Syndrome Type II

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Autoimmune polyendocrine syndrome type II

patients with autoimmune polyendocrine syndrome type II

no intervention

Intervention Type OTHER

No intervention, only observation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

no intervention

No intervention, only observation

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients visited NTUH during 2006-2021, and had at least two of the three diseases: type 1 DM, primary adrenal insufficiency, and autoimmune thyroid disease.